| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77 Stockholm, Sweden1
Author for correspondence: Katja Pokrovskaja. Fax +46 8 33 04 98. e-mail katpok{at}ki.se
We have previously shown that Epstein–Barr virus (EBV)-encoded EBNA-5 is localized to PML bodies (PODs) in EBV-immortalized lymphoblastoid cell lines (LCLs). Here we have extended our study of the subnuclear localization of EBNA-5 and found a strict co-localization with PML in LCLs and in BL lines with an immunoblastic, LCL-like phenotype. Moreover, GFP–EBNA-5 accumulated in PML bodies upon transfection into LCLs. In contrast, transfection of cell lines of non-immunoblastic origin with an EBNA-5 expression construct showed preferential localization of the protein to the nucleoplasm. Since PML is involved in proteasome-dependent protein degradation, we investigated the total levels and sub-cellular localization of EBNA-5 upon inhibition of proteasome activity. We found that a proteasome inhibitor, MG132, induced the translocation of both endogenous and transfected EBNA-5 to the nucleoli in every cell line tested. The total EBNA-5 protein levels were not affected by the proteasomal block. EBNA-5 forms complexes with heat shock protein Hsp70. The proteasome inhibitor induced a rise in total levels of Hsp70 and dramatically changed its homogeneous nuclear and cytoplasmic distribution into nucleolar and cytoplasmic. This effect was EBNA-5-independent. The nucleolar localization of Hsp70 was enhanced by the presence of EBNA-5, however. EBNA-5 also enhanced the nucleolar translocation of a mutant p53 in a colon cancer line, SW480, treated with MG132. The coordinated changes in EBNA-5 and Hsp70 localization and the effect of EBNA-5 on mutant p53 distribution upon MG132 treatment might reflect the involvement of EBNA-5 in the regulation of intracellular protein trafficking associated with the proteasome-mediated degradation.
This article has been cited by other articles:
|
|
 |
|
  O. Karni-Schmidt, A. Zupnick, M. Castillo, A. Ahmed, T. Matos, P. Bouvet, C. Cordon-Cardo, and C. Prives p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner J. Cell Sci., December 15, 2008; 121(24): 4098 - 4105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Viiri, H. Korkeamaki, M. K. Kukkonen, L. K. Nieminen, K. Lindfors, P. Peterson, M. Maki, H. Kainulainen, and O. Lohi SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus Nucleic Acids Res., July 4, 2006; 34(11): 3288 - 3298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Stavreva, M. Kawasaki, M. Dundr, K. Koberna, W. G. Muller, T. Tsujimura-Takahashi, W. Komatsu, T. Hayano, T. Isobe, I. Raska, et al. Potential Roles for Ubiquitin and the Proteasome during Ribosome Biogenesis. Mol. Cell. Biol., July 1, 2006; 26(13): 5131 - 5145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Kashuba, K. Gradin, M. Isaguliants, L. Szekely, L. Poellinger, G. Klein, and A. Kazlauskas Regulation of Transactivation Function of the Aryl Hydrocarbon Receptor by the Epstein-Barr Virus-encoded EBNA-3 Protein J. Biol. Chem., January 13, 2006; 281(2): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Madureira, P. Matos, I. Soeiro, L. K. Dixon, J. P. Simas, and E. W.-F. Lam Murine {gamma}-Herpesvirus 68 Latency Protein M2 Binds to Vav Signaling Proteins and Inhibits B-cell Receptor-induced Cell Cycle Arrest and Apoptosis in WEHI-231 B Cells J. Biol. Chem., November 11, 2005; 280(45): 37310 - 37318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Peng, S. C. Moses, J. Tan, E. Kremmer, and P. D. Ling The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter J. Virol., April 1, 2005; 79(7): 4492 - 4505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. I. Kashuba, J. Li, F. Wang, V. N. Senchenko, A. Protopopov, A. Malyukova, A. S. Kutsenko, E. Kadyrova, V. I. Zabarovska, O. V. Muravenko, et al. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies PNAS, April 6, 2004; 101(14): 4906 - 4911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Chatterjee and R. A. Fisher Mild Heat and Proteotoxic Stress Promote Unique Subcellular Trafficking and Nucleolar Accumulation of RGS6 and Other RGS Proteins: ROLE OF THE RGS DOMAIN IN STRESS-INDUCED TRAFFICKING OF RGS PROTEINS J. Biol. Chem., August 8, 2003; 278(32): 30272 - 30282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Arabi, C. Rustum, E. Hallberg, and A. P. H. Wright Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels J. Cell Sci., May 1, 2003; 116(9): 1707 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mattsson, C. Kiss, G. M. Platt, G. R. Simpson, E. Kashuba, G. Klein, T. F. Schulz, and L. Szekely Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions J. Gen. Virol., January 1, 2002; 83(1): 179 - 188. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
